[go: up one dir, main page]

ES2190925T3 - Gen del cancer de prostata. - Google Patents

Gen del cancer de prostata.

Info

Publication number
ES2190925T3
ES2190925T3 ES00115991T ES00115991T ES2190925T3 ES 2190925 T3 ES2190925 T3 ES 2190925T3 ES 00115991 T ES00115991 T ES 00115991T ES 00115991 T ES00115991 T ES 00115991T ES 2190925 T3 ES2190925 T3 ES 2190925T3
Authority
ES
Spain
Prior art keywords
prostate cancer
biallelic markers
methods
relates
biallelic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00115991T
Other languages
English (en)
Inventor
Daniel Cohen
Marta Blumenfeld
Ilya Chumakou
Lydie Bougueleret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/996,306 external-priority patent/US5945522A/en
Application filed by Genset SA filed Critical Genset SA
Application granted granted Critical
Publication of ES2190925T3 publication Critical patent/ES2190925T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un método de genotipaje que comprende determinar la identidad de un nucleotido de un marcador bialélico relacionado con PG1 en una muestra biológica, en el que dicho nucleotido de dicho marcador bialélico relacionado con PG1 es seleccionado del grupo que consiste en:
ES00115991T 1997-12-22 1998-12-22 Gen del cancer de prostata. Expired - Lifetime ES2190925T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/996,306 US5945522A (en) 1997-12-22 1997-12-22 Prostate cancer gene
US9965898P 1998-09-09 1998-09-09

Publications (1)

Publication Number Publication Date
ES2190925T3 true ES2190925T3 (es) 2003-09-01

Family

ID=26796342

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00115991T Expired - Lifetime ES2190925T3 (es) 1997-12-22 1998-12-22 Gen del cancer de prostata.

Country Status (11)

Country Link
US (1) US6346381B1 (es)
EP (1) EP0991770B1 (es)
JP (1) JP3889927B2 (es)
AT (2) ATE236998T1 (es)
AU (1) AU750183B2 (es)
CA (1) CA2311416A1 (es)
DE (2) DE69813302T2 (es)
DK (1) DK1052292T3 (es)
ES (1) ES2190925T3 (es)
PT (1) PT1052292E (es)
WO (1) WO1999032644A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105353B2 (en) 1997-07-18 2006-09-12 Serono Genetics Institute S.A. Methods of identifying individuals for inclusion in drug studies
CA2324869A1 (en) * 1998-04-09 1999-10-21 Whitehead Institute For Biomedical Research Biallelic markers
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
EP1071817A2 (en) * 1998-04-21 2001-01-31 Genset Biallelic markers for use in constructing a high density disequilibrium map of the human genome
US6825004B1 (en) 1998-08-07 2004-11-30 Genset S.A. Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
AU774440B2 (en) * 1998-08-07 2004-06-24 Genset S.A. Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
JP2002529718A (ja) 1998-11-10 2002-09-10 ジェンセット 検出可能な形質と結合された遺伝子を含むゲノム領域を同定するための方法、ソフトウエアおよび装置
ES2284508T3 (es) * 1999-07-27 2007-11-16 Adnexus Therapeutics, Inc. Procedimientos de ligadura de aceptador de peptidos.
WO2001014550A1 (en) * 1999-08-19 2001-03-01 Genset Prostate cancer-relased gene 3 (pg-3) and biallelic markers thereof
AU1358401A (en) * 1999-11-09 2001-06-06 Cell Therapeutics, Inc. Human lysophosphatidic acid acyltransferase-epsilon
US6562955B2 (en) * 2000-03-17 2003-05-13 Tosoh Corporation Oligonucleotides for detection of Vibrio parahaemolyticus and detection method for Vibrio parahaemolyticus using the same oligonucleotides
US20030195707A1 (en) * 2000-05-25 2003-10-16 Schork Nicholas J Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20020077775A1 (en) * 2000-05-25 2002-06-20 Schork Nicholas J. Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US7567870B1 (en) * 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
US7993907B2 (en) * 2001-05-08 2011-08-09 Mowycal Lending, Llc Biochips and method of screening using drug induced gene and protein expression profiling
US7343247B2 (en) * 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
US20040197845A1 (en) * 2002-08-30 2004-10-07 Arjang Hassibi Methods and apparatus for pathogen detection, identification and/or quantification
TWI340168B (en) 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
JP5629894B2 (ja) * 2004-12-07 2014-11-26 国立大学法人大阪大学 甲状腺乳頭癌を診断するための新規のマーカー
DE102005022047A1 (de) * 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
BRPI0610794A2 (pt) * 2005-05-18 2010-11-09 Decore Genetics Ehf métodos para diagnosticar uma susceptibilidade a um cáncer e para predizer um risco aumentado de cáncer, kit para ensaiar uma amostra de um indivìduo para detectar uma susceptibilidade a um cáncer, e, métodos para diagnosticar um risco aumentado de cáncer e para diagnosticar um cáncer associado com chr8q24.21
NZ596070A (en) * 2009-05-08 2013-10-25 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
JP6034782B2 (ja) 2010-05-25 2016-11-30 ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ Ｂａｍｂａｍ：ハイスループットシークエンシングデータの同時比較解析
US9646134B2 (en) 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
AU2013242403B2 (en) * 2012-03-27 2018-10-18 Curevac Ag Artificial nucleic acid molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459037A (en) 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5658730A (en) 1994-12-23 1997-08-19 Ctrc Research Foundation Methods of human prostate cancer diagnosis
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US5925519A (en) * 1996-06-03 1999-07-20 The Regents Of The University Of California Genetic alterations associated with prostate cancer

Also Published As

Publication number Publication date
EP0991770A2 (en) 2000-04-12
DE69800415D1 (de) 2001-01-04
WO1999032644A3 (en) 1999-09-10
US6346381B1 (en) 2002-02-12
AU1574099A (en) 1999-07-12
WO1999032644A2 (en) 1999-07-01
DE69813302D1 (de) 2003-05-15
DE69800415T2 (de) 2001-07-19
ATE197817T1 (de) 2000-12-15
CA2311416A1 (en) 1999-07-01
EP0991770B1 (en) 2000-11-29
ATE236998T1 (de) 2003-04-15
AU750183B2 (en) 2002-07-11
DE69813302T2 (de) 2003-12-11
JP2002516657A (ja) 2002-06-11
JP3889927B2 (ja) 2007-03-07
DK1052292T3 (da) 2003-07-28
PT1052292E (pt) 2003-06-30

Similar Documents

Publication Publication Date Title
ES2190925T3 (es) Gen del cancer de prostata.
Ginzinger et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis
Asamura et al. MiniX-STR multiplex system population study in Japan and application to degraded DNA analysis
Yin et al. Multiple single nucleotide polymorphisms on human chromosome 19q13. 2–3 associate with risk of Basal cell carcinoma
ATE469982T1 (de) Bestimmung des genotyps eines amplifikationsproduktes an mehreren allelen stellen
BR0308134A (pt) análise rápida das variações em um genoma
WO1990013668A1 (en) Method for genetic analysis of a nucleic acid sample
Frühwald et al. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon
Wu et al. Genomic alterations in ectopic and eutopic endometria of women with endometriosis
WO2000047771A3 (en) Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
Petkovski et al. SNPs and MALDI-TOF MS: tools for DNA typing in forensic paternity testing and anthropology
Lee et al. Polymorphism in the mitochondrial cytochrome B gene in Koreans: an additional marker for individual identification
DE60041912D1 (de) Polymorphe marker des lsr-gens
US5773649A (en) DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
ATE397064T1 (de) Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
Gasparini et al. Detection of a neurofibromatosis type I (NF1) homologous sequence by PCR: implications for the diagnosis and screening of genetic diseases
Sanchez et al. Duplications of the Y-chromosome specific loci P25 and 92R7 and forensic implications
Kang et al. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer
Nakamura et al. Simple and accurate determination of CYP2D6 gene copy number by a loop-mediated isothermal amplification method and an electrochemical DNA chip
Sánchez-García et al. Multiplex fluorescent analysis of four short tandem repeats for rapid haemophilia A molecular diagnosis
DE60040231D1 (de) Biallelische Marker die im zusammenhang stehen mit Medikamentenmetabolismus beteiligten Genen
Zheng et al. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study
Haeusler et al. Association of a CAV‐1 haplotype to familial aggressive prostate cancer
Yu et al. ADLAPH: A molecular haplotyping method based on allele-discriminating long-range PCR